1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NBPF15 CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA ITGB1 CTRPv2 pan-cancer AAC -0.18 4e-06
mRNA POLD4 CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA LAMB2 CTRPv2 pan-cancer AAC -0.18 5e-06
mRNA REEP5 CTRPv2 pan-cancer AAC -0.18 4e-06
mRNA MCFD2 CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA ROMO1 CTRPv2 pan-cancer AAC -0.18 5e-07
mRNA RAB13 CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA UEVLD CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA TCTN3 CTRPv2 pan-cancer AAC -0.17 1e-06
Download CSV